查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573083

Butorphanol市場：按產品類型、應用和分銷管道分類 - 全球預測 2025-2030

Butorphanol Market by Product Type (Injection, Nasal Spray), Application (Cancer Pain, Labor Pain, Migraine Pain), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年Butorphanol市值為2.7147億美元，預計2024年將達到2.8374億美元，複合年成長率為4.30%，預計到2030年將達到3.6475億美元。

Butorphanol是一種用於疼痛管理的鴉片類鎮痛藥，在醫療保健環境中具有多種用途，包括緩解分娩和手術期間的疼痛，以及控制對其他鴉片類鎮痛藥有抵抗力的患者的疼痛。對Butorphanol的需求在於其在治療中度至重度疼痛方面的有效性，特別是在替代藥物無效或不合適的情況下。其應用範圍擴展到醫院、手術中心和獸醫等最終用戶。市場範圍包括製藥、醫療機構、獸醫醫院等，需要穩定的供應以滿足多樣化的疼痛管理需求。

主要市場統計
基準年[2023] 27147萬美元
預測年份 [2024] 2.8374億美元
預測年份 [2030] 36475萬美元
複合年成長率（%） 4.30%

目前的市場分析強調，慢性疼痛和手術相關手術的日益普及是關鍵的成長要素，推動了對Butorphanol等有效止痛藥的需求不斷成長。此外，醫療保健提供者對疼痛管理方案的認知不斷提高也推動了市場的擴張。透過擴大Butorphanol的獸醫應用，專注於牲畜和寵物，並將其引入缺乏強大疼痛管理解決方案的新興市場，存在潛在的機會。與醫療機構和動物用藥品公司的策略聯盟和夥伴關係可以進一步擴大市場佔有率。

然而，市場面臨限制和挑戰，特別是在鴉片類藥物相關法規以及成癮和濫用風險方面，這可能會阻礙成長。鴉片類藥物的負面形象需要嚴格遵守監管指南，並可能影響市場滲透率。此外，替代性非鴉片類止痛藥的出現可能會減少對Butorphanol的需求。

創新需要開發成癮性較低的配方，並研究和開發最佳化功效和安全性的輸送系統。此外，強調其獨特的藥理學方面可能會帶來進步，並有可能在更廣泛的鴉片類藥物市場中開闢一席之地。總體而言，市場競爭仍然激烈，但前景廣闊，在不同的應用和地區都有成長空間，這表明將重點放在創新和戰略市場定位，以充分利用Butorphanol帶來的機會。

市場動態：揭示快速發展的Butorphanol市場的關鍵市場洞察

供需的動態交互作用正在改變Butorphanol市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 影響Butorphanol供應鏈物流的嚴格監管政策和指南
    • 擴大Butorphanol在動物用藥品和動物保健品市場的應用
    • 製藥公司與研究機構合作開發新藥
    • 醫療費用上漲，加大疼痛管理研發投入
  • 市場限制因素
    • 由於替代性疼痛管理療法的市場競爭，Butorphanol的市場佔有率可能會下降
    • Butorphanol諾合成和製造流程的高成本推高了整體市場定價
  • 市場機會
    • 探索已開發地區對Butorphanol作為疼痛管理解決方案不斷成長的需求
    • Butorphanol作為動物鎮痛藥在獸醫領域的發展潛力分析
    • 隨著醫療保健機會的增加，調查Butorphanol在新興國家的市場擴張機會
  • 市場挑戰
    • 嚴格的監管核准和高成本限制影響Butorphanol市場擴張
    • 新興市場對Butorphanol作為疼痛管理解決方案的認知和採用率較低

波特的五力：駕馭Butorphanol市場的策略工具

波特的五力架構是了解Butorphanol市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解Butorphanol市場的外部影響

外部宏觀環境因素在塑造Butorphanol市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解Butorphanol市場的競爭格局

Butorphanol市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣Butorphanol市場供應商的績效評估

FPNV定位矩陣是評估Butorphanol市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了Butorphanol市場的成功之路

Butorphanol市場的策略分析對於旨在加強其在全球市場的影響力的公司至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 影響Butorphanol供應鏈物流的嚴格監管政策和指南
      • 擴大Butorphanol在獸醫和動物保健市場的應用
      • 製藥公司與研究機構合作開發先進藥物
      • 增加醫療支出和疼痛管理研發投資
    • 抑制因素
      • 替代疼痛管理療法的市場競爭可能會減少Butorphanol的市場佔有率
      • Butorphanol諾合成和製造流程的高成本導致整個市場的價格上漲
    • 機會
      • 調查已開發地區對Butorphanol作為疼痛管理解決方案不斷成長的需求
      • 分析Butorphanol在獸醫藥物中緩解動物疼痛的成長潛力
      • 隨著醫療保健的普及，調查Butorphanol在新興國家的市場擴張機會
    • 任務
      • 嚴格的監管核准和高成本限制影響Butorphanol市場擴張
      • 新興市場對Butorphanol作為疼痛管理解決方案的認知和採用有限
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章Butorphanol市場：依產品類型

  • 注射
  • 鼻噴劑

第7章Butorphanol市場：依應用分類

  • 癌症痛
  • 陣痛
  • 偏頭痛
  • 術後疼痛

第8章Butorphanol市場：依通路分類

  • 離線
  • 線上

第9章 美洲Butorphanol市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太布托Butorphanol市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲Butorphanol市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C0322

The Butorphanol Market was valued at USD 271.47 million in 2023, expected to reach USD 283.74 million in 2024, and is projected to grow at a CAGR of 4.30%, to USD 364.75 million by 2030.

Butorphanol is an opioid analgesic used for pain management, encompassing a variety of applications in healthcare settings, such as pain relief during labor or surgery and controlling pain in patients resistant to other opioid analgesics. The necessity of Butorphanol lies in its efficacy in managing moderate to severe pain, particularly in scenarios where alternatives may not be effective or suitable. Its application extends to end-users in hospitals, surgical centers, and veterinary medicine. The market scope includes pharmaceuticals, healthcare institutions, and veterinary practices, demanding consistent supply to address diverse pain management needs.

KEY MARKET STATISTICS
Base Year [2023] USD 271.47 million
Estimated Year [2024] USD 283.74 million
Forecast Year [2030] USD 364.75 million
CAGR (%) 4.30%

Current market insights emphasize the increasing prevalence of chronic pain conditions and surgery-related procedures as key growth influencers, driving heightened demand for effective analgesics like Butorphanol. Additionally, rising awareness regarding pain management options among healthcare providers bolsters market expansion. Potential opportunities lie in expanding the veterinary application of Butorphanol, focusing on livestock and pets, and introducing it into emerging markets lacking robust pain management solutions. Strategic collaborations and partnerships with healthcare institutions and veterinary pharmaceutical companies can further augment market presence.

However, the market faces limitations and challenges, especially concerning opioid-related regulations and the risk of addiction and misuse, which can hinder growth. The negative perception surrounding opioids necessitates stringent compliance with regulatory guidelines, possibly affecting market penetration. Furthermore, the advent of alternative non-opioid pain relievers may dampen Butorphanol's demand.

For innovation, research could focus on developing Butorphanol formulations with reduced addictive properties or delivery systems optimizing its efficacy and safety profile. Emphasizing its unique pharmacological aspects may also yield advancements, potentially carving out a niche within the broader opioid market. Overall, the market remains competitive but promising, with scope for growth in diversified applications and regions, suggesting a focus on innovation and strategic market positioning to fully leverage the opportunities Butorphanol presents.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Butorphanol Market

The Butorphanol Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Stringent regulatory policies and guidelines affecting the Butorphanol supply chain logistics
    • Expanding applications of Butorphanol in veterinary medicine and animal healthcare markets
    • Collaborative efforts between pharmaceutical companies and research institutions for advanced drug development
    • Increasing healthcare expenditure and investment in pain management research and development
  • Market Restraints
    • Market competition from alternative pain management therapies may erode butorphanol's market share
    • High cost of butorphanol synthesis and production processes increases overall market pricing
  • Market Opportunities
    • Exploring the rise in demand for Butorphanol as a pain management solution in developed regions
    • Analyzing the growth potential of Butorphanol in veterinary medicine for animal pain relief
    • Investigating the market expansion opportunities for Butorphanol in emerging countries with increasing healthcare access
  • Market Challenges
    • Stringent regulatory approvals and high-cost constraints affecting butorphanol market expansion
    • Limited awareness and adoption of butorphanol as a pain management solution in emerging markets

Porter's Five Forces: A Strategic Tool for Navigating the Butorphanol Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Butorphanol Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Butorphanol Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Butorphanol Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Butorphanol Market

A detailed market share analysis in the Butorphanol Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Butorphanol Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Butorphanol Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Butorphanol Market

A strategic analysis of the Butorphanol Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Butorphanol Market, highlighting leading vendors and their innovative profiles. These include Akorn, Inc., Amneal Pharmaceuticals, Inc., Aurobindo Pharma USA, Inc., BioDelivery Sciences International, Inc., Egalet Corporation, Endo Pharmaceuticals Inc., Esteve Pharmaceuticals, Fresenius Kabi USA, LLC, Hikma Pharmaceuticals PLC, Hospira, Inc., Johnson & Johnson, Lupin Pharmaceuticals, Inc., Mallinckrodt Pharmaceuticals, Mylan N.V., Novartis International AG, Pfizer Inc., Purdue Pharma L.P., Sanofi S.A., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Butorphanol Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Injection and Nasal Spray.
  • Based on Application, market is studied across Cancer Pain, Labor Pain, Migraine Pain, and Postoperative Pain.
  • Based on Distribution Channel, market is studied across Offline and Online.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Stringent regulatory policies and guidelines affecting the Butorphanol supply chain logistics
      • 5.1.1.2. Expanding applications of Butorphanol in veterinary medicine and animal healthcare markets
      • 5.1.1.3. Collaborative efforts between pharmaceutical companies and research institutions for advanced drug development
      • 5.1.1.4. Increasing healthcare expenditure and investment in pain management research and development
    • 5.1.2. Restraints
      • 5.1.2.1. Market competition from alternative pain management therapies may erode butorphanol's market share
      • 5.1.2.2. High cost of butorphanol synthesis and production processes increases overall market pricing
    • 5.1.3. Opportunities
      • 5.1.3.1. Exploring the rise in demand for Butorphanol as a pain management solution in developed regions
      • 5.1.3.2. Analyzing the growth potential of Butorphanol in veterinary medicine for animal pain relief
      • 5.1.3.3. Investigating the market expansion opportunities for Butorphanol in emerging countries with increasing healthcare access
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approvals and high-cost constraints affecting butorphanol market expansion
      • 5.1.4.2. Limited awareness and adoption of butorphanol as a pain management solution in emerging markets
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Butorphanol Market, by Product Type

  • 6.1. Introduction
  • 6.2. Injection
  • 6.3. Nasal Spray

7. Butorphanol Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer Pain
  • 7.3. Labor Pain
  • 7.4. Migraine Pain
  • 7.5. Postoperative Pain

8. Butorphanol Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Americas Butorphanol Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Butorphanol Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Butorphanol Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akorn, Inc.
  • 2. Amneal Pharmaceuticals, Inc.
  • 3. Aurobindo Pharma USA, Inc.
  • 4. BioDelivery Sciences International, Inc.
  • 5. Egalet Corporation
  • 6. Endo Pharmaceuticals Inc.
  • 7. Esteve Pharmaceuticals
  • 8. Fresenius Kabi USA, LLC
  • 9. Hikma Pharmaceuticals PLC
  • 10. Hospira, Inc.
  • 11. Johnson & Johnson
  • 12. Lupin Pharmaceuticals, Inc.
  • 13. Mallinckrodt Pharmaceuticals
  • 14. Mylan N.V.
  • 15. Novartis International AG
  • 16. Pfizer Inc.
  • 17. Purdue Pharma L.P.
  • 18. Sanofi S.A.
  • 19. Sun Pharmaceutical Industries Ltd.
  • 20. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. BUTORPHANOL MARKET RESEARCH PROCESS
  • FIGURE 2. BUTORPHANOL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BUTORPHANOL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BUTORPHANOL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BUTORPHANOL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BUTORPHANOL MARKET DYNAMICS
  • TABLE 7. GLOBAL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BUTORPHANOL MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BUTORPHANOL MARKET SIZE, BY NASAL SPRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BUTORPHANOL MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BUTORPHANOL MARKET SIZE, BY LABOR PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BUTORPHANOL MARKET SIZE, BY MIGRAINE PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BUTORPHANOL MARKET SIZE, BY POSTOPERATIVE PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BUTORPHANOL MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BUTORPHANOL MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES BUTORPHANOL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA BUTORPHANOL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM BUTORPHANOL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. BUTORPHANOL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. BUTORPHANOL MARKET, FPNV POSITIONING MATRIX, 2023